Krystal Biotech (KRYS) Operating Income (2021 - 2025)
Historic Operating Income for Krystal Biotech (KRYS) over the last 5 years, with Q4 2025 value amounting to $44.3 million.
- Krystal Biotech's Operating Income rose 699.7% to $44.3 million in Q4 2025 from the same period last year, while for Dec 2025 it was $161.1 million, marking a year-over-year increase of 14513.99%. This contributed to the annual value of $161.3 million for FY2025, which is 14532.31% up from last year.
- Krystal Biotech's Operating Income amounted to $44.3 million in Q4 2025, which was up 699.7% from $41.4 million recorded in Q3 2025.
- In the past 5 years, Krystal Biotech's Operating Income ranged from a high of $44.3 million in Q4 2025 and a low of -$50.2 million during Q1 2022
- For the 5-year period, Krystal Biotech's Operating Income averaged around -$4.8 million, with its median value being -$15.0 million (2021).
- As far as peak fluctuations go, Krystal Biotech's Operating Income plummeted by 24990.59% in 2022, and later soared by 117386.08% in 2024.
- Over the past 5 years, Krystal Biotech's Operating Income (Quarter) stood at -$21.9 million in 2021, then crashed by 58.95% to -$34.8 million in 2022, then skyrocketed by 109.34% to $3.2 million in 2023, then skyrocketed by 1173.86% to $41.4 million in 2024, then increased by 7.0% to $44.3 million in 2025.
- Its last three reported values are $44.3 million in Q4 2025, $41.4 million for Q3 2025, and $39.3 million during Q2 2025.